Keywords
How to Cite
Abstract views: 454 PDF Downloads: 1909
Abstract
The 56th meeting of the European Pancreatic Club took place in Santiago de Compostela (Spain) on June 26–29, 2024. The eminent pancreatologist Professor J. Enrique Domínguez-Muñoz was the President of the Congress. The meeting got 21 abstracts from Ukraine, all of which received acceptance and will appear in the Pancreatology journal. Twelve doctors from Ukraine (Kyiv, Odesa, Kharkiv, Zaporizhzhia, and Vinnytsia) attended the meeting. Our Club members from Moldova, Kazakhstan, and Georgia also arrived. The most important event was the adoption of the “European guidelines for the diagnosis and treatment of pancreatic exocrine insufficiency (EPI): UEG, EPC, EDS, ESPEN, ESPGHAN, ESDO, and ESPCG recommendations.” The European Pancreatic Club meeting featured a number of papers that focused on PEI. The study “Optimal dose of enzyme replacement therapy (ERT) for PEI in various pancreatic diseases: results of the European PEI registry” stands out as one of the most significant. The study was conducted under the supervision of Professor J. Enrique Domínguez-Muñoz (Spain). Pancreatologists from Spain, Hungary, Italy, France, and Great Britain participated in compiling the registry. Expert pancreatology centers contributed to the creation of a prospective multicenter European PEI registry.
Djuna L. Cahen (Netherlands) gave a lecture on PEI in patients with diabetes. ERT is important for preventing diabetes complications (osteoporosis, reducing pancreatic cancer, cardiovascular risk).
Under the supervision of Miroslav Vujasinovic (Sweden), a systematic review and meta-analysis of “Prevalence of PEI and ERT in diabetes” yielded important results for science and practice. Studies concerning the diagnostic capabilities of endosonography in pancreatic pathology, especially in chronic pancreatitis (CP), received particular attention.
Miroslav Vujasinovic (Sweden) presented modern data on the epidemiology, pathogenesis, and diagnostics of non-alcoholic fatty pancreatic disease in his lecture. Even though a lot of research has been done on this topic, non-alcoholic fatty pancreatic disease is still a “mystery” for pancreatologists. This is because important issues like a unified nomenclature, accurate information on prevalence, optimal biomarkers and diagnostic criteria, including the disease in the International Classification of Diseases, establishing clinical significance, and treatment are still not clear-cut and up for debate.
- Dominguez-Novoa et al. (Spain) conducted a series of studies. The study, “Long-term dynamics of exocrine and endocrine functions of the pancreas in early CP and factors influencing this dynamics”, yielded significant findings. Interestingly, smoking was the primary factor in PEI progression. Matteo Piciucchi et al. (Italy) presented data from the Italian CP registry (ITA RECIPE) and preliminary results of a prospective nationwide cohort study in which 50 centers participated.
References
2. Alexandre-Heymann L., Yaker F., Lassen P. B., Dubois-Laforgue D., Larger E. Pancreatic enzyme replacement therapy in subjects with exocrine pancreatic insufficiency and diabetes mellitus: a real-life, case-control study. Diabetol. Metab. Syndr. 2024. Vol. 16, No 1. P. 39.
3. Babajide O., Desai A., Eruchalu C., Sedarous M., Adekunle D., Youssef M., Mahmud M., Okafor P. N. The Population-level Prevalence of Exocrine Pancreas Insufficiency and the Subsequent Risk of Pancreatic Cancer. Pancreas. 2024. Vol. 53, No 9. Р. e723-e728.
4. de la Iglesia D., Vallejo-Senra N., López-López A., Iglesias-Garcia J., Lariño-Noia J., Nieto-García L., Domínguez-Muñoz J. E. Pancreatic exocrine insufficiency and cardiovascular risk in patients with chronic pancreatitis: A prospective, longitudinal cohort study. J. Gastroenterol. Hepatol. 2019. Vol. 34, No 1. P. 277–283.
5. Ewald N., Bretzel R. G., Fantus I. G., Hollenhorst M., Kloer H. U., Hardt P. D., S-2453110 Study Group. Pancreatin therapy in patients with insulin-treated diabetes mellitus and exocrine pancreatic insufficiency according to low fecal elastase 1 concentrations. Results of a prospective multi-centre trial. Diabetes Metab. Res. Rev. 2007. Vol. 23, No 5. P. 386–391.
6. Feng X., Li X. The prevalence of small intestinal bacterial overgrowth in diabetes mellitus: a systematic review and meta-analysis. Aging (Albany NY). 2022. Vol. 14. P. 975–988.
7. Hahn J. U., Kerner W., Maisonneuve P., Lowenfels A. B., Lankisch P. G. Low fecal elastase 1 levels do not indicate exocrine pancreatic insufficiency in type-1 diabetes mellitus. Pancreas. 2008. Vol. 36, No 3. P. 274–278.
8. Levine M. E., Koch S. Y., Koch K. L. Lipase Supplementation before a High-Fat Meal Reduces Perceptions of Fullness in Healthy Subjects. Gut Liver. 2015. Vol. 9, No 4. P. 464–469.
9. Lewis D. An Updated Review of Exocrine Pancreatic Insufficiency Prevalence finds EPI to be More Common in General Population than Rates of Co-Conditions. J. Gastrointestin. Liver Dis. 2024. Vol. 33, No 1. P. 123–130.
10. Lewis D. M. A Systematic Review of Exocrine Pancreatic Insufficiency Prevalence and Treatment in Type 1 and Type 2 Diabetes. Diabetes Technol. Ther. 2023. Vol. 25, No 9. P. 659–672.
11. Lindkvist B., Nilsson C., Kvarnström M., Oscarsson J. Importance of pancreatic exocrine dysfunction in patients with type 2 diabetes: A randomized crossover study. Pancreatology. 2018. Vol. 18, No 5. P. 550–558.
12. Lipp M., Tarján D., Lee J., Zolcsák Á., Szalai E., Teutsch B., Faluhelyi N., Erőss B., Hegyi P., Mikó A. Fatty Pancreas Is a Risk Factor for Pancreatic Cancer: A Systematic Review and Meta-Analysis of 2956 Patients. Cancers (Basel). 2023. Vol. 15, No 19. P. 4876.
13. Liu X., Chen F., Liu L., Zhang Q. Prevalence of osteoporosis in patients with diabetes mellitus: a systematic review and meta-analysis of observational studies. BMC Endocr. Disord. 2023. Vol. 23, No 1. P. 1.
14. Maetzel H., Rutkowski W., Panic N., Mari A., Hedström A., Kulinski P., Stål P., Petersson S., Brismar T. B., Löhr J. M., Vujasinovic M. Non-alcoholic fatty pancreas disease and pancreatic exocrine insufficiency: pilot study and systematic review. Scand. J. Gastroenterol. 2023. Vol. 58, No 9. P. 1030–1037.
15. Min M., Patel B., Han S., Bocelli L., Kheder J., Vaze A., Wassef W. Exocrine Pancreatic Insufficiency and Malnutrition in Chronic Pancreatitis: Identification, Treatment, and Consequences. Pancreas. 2018. Vol. 47, No 8. P. 1015–1018.
16. Petrov M. S., Basina M. Diagnosis of endocrine disease: Diagnosing and classifying diabetes in diseases of the exocrine pancreas. Eur. J. Endocrinol. 2021. Vol. 184, No 4. P. R151–163.
17. Radlinger B., Ramoser G., Kaser S. Exocrine Pancreatic Insufficiency in Type 1 and Type 2 Diabetes. Curr. Diab. Rep. 2020. Vol. 20, No 6. P. 18.
18. Rugivarodom M., Geeratragool T., Pausawasdi N., Charatcharoenwitthaya P. Fatty Pancreas: Linking Pancreas Pathophysiology to Nonalcoholic Fatty Liver Disease. J. Clin. Transl. Hepatol. 2022. Vol. 10, No 6. P. 1229–1239.
19. Schepis T., Tringali A., Spada C., Costamagna G., Boškoski I. Intrapancreatic Fat Deposition: Cause or Consequence of First Acute Pancreatitis Attack? Am. J. Gastroenterol. 2023. Vol. 118, No 5. P. 910–911.
20. Søfteland E., Poulsen J. L., Starup-Linde J., Christensen T. T., Olesen S. S., Singh S., Vestergaard P., Drewes A. M., Dimcevski G. Pancreatic exocrine insufficiency in diabetes mellitus — prevalence and characteristics. Eur. J. Intern. Med. 2019. Vol. 68. P. 18–22.
21. Whitcomb D. C., Shimosegawa T., Chari S. T., Forsmark C. E., Frulloni L., Garg P., Hegyi P., Hirooka Y., Irisawa A., Ishikawa T., Isaji S., Lerch M. M., Levy P., Masamune A., Wilcox C. M., Windsor J., Yadav D., Sheel A., Neoptolemos J. P., Working Group for the International (IAP — APA — JPS — EPC) Consensus Guidelines for Chronic Pancreatitis. International consensus statements on early chronic Pancreatitis. Recommendations from the working group for the international consensus guidelines for chronic pancreatitis in collaboration with The International Association of Pancreatology, American Pancreatic Association, Japan Pancreas Society, PancreasFest Working Group and European Pancreatic Club. Pancreatology. 2018. Vol. 18, No 5. P. 516–527.
22. Zhang J., Hou J., Liu D., Lv Y., Zhang C., Su X., Li L. The Prevalence and Characteristics of Exocrine Pancreatic Insufficiency in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis. Int. J. Endocrinol. 2022. Vol. 2022. P. 7764963.